Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...
The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.
Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...
Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs impacted by the uncertainty surrounding federal grants.
The cuts hit the FDA’s medical device center particularly hard, impacting product reviewers and researchers of AI-enabled ...
Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...
Chris Gibson, Recursion’s head, cited the role small business grants played in helping his company grow its business.
If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...
Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.
A list of 15 grants for minority and women-owned businesses offering $50,000 - $2 million in funding, along with specific ...
1d
Dealbreaker on MSNRecursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH TumultAltitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results